Genpact Q2 ATS Surge Validates Agentic Operations Pivot, Strengthening Buy Case

What happened

Genpact's second quarter 2026 results featured a 24% year-over-year surge in Advanced Technology Solutions revenue, confirming the accelerating shift toward higher-value Agentic Operations. This performance underscores the company's flywheel gaining momentum, as CEO Balkrishan Kalra noted that the pivot is 'taking hold faster.' The result directly supports the investment thesis that increasing ATS mix will drive margin expansion and rerating potential. With diversified end-markets and a robust partner ecosystem, Genpact appears well-positioned to sustain double-digit growth in its most differentiated offerings. The quarter adds tangible evidence to the strategic narrative, reducing execution risk for the bull case.

Implication

The 24% ATS growth rate likely outpaces market expectations, signaling that Genpact’s transition to Agentic Operations is ahead of schedule. This strengthens confidence in sustained mix improvement, margin expansion, and free cash flow generation. Investors should expect continued capital returns and potential upward revisions to growth assumptions. The valuation gap versus large-cap peers should compress as the market re-rates the stock for higher-quality, technology-led revenue. While risks around pilot conversion and legacy BPO pricing remain, the quarter meaningfully de-risks the 'pivot to growth' narrative and supports a BUY rating.

Thesis delta

The Q2 2026 result reinforces the existing BUY thesis, with ATS growth outpacing prior expectations. The accelerating flywheel suggests the strategic pivot is succeeding sooner than anticipated, increasing conviction in the rerating story. No change to stance; risk/reward has improved.